Product Characterization

Ensure Successful Approval of Biologics With a Complete Product Characterization Solution

Successful approval of biologics depends on robust product characterization — an analytical data package that defines the characteristics and structure of the biotherapeutic and proves the safety, efficacy, purity, quality, and strength. This in-depth analysis is not only required for compliance with FDA and EMA/MHRA guidelines, the information gathered also informs critical decisions as the product moves through each phase of the pipeline, from candidate selection to transferring processes to commercial-scale manufacturing.

Sartorius helps manufacturers advance drug candidates from early-stage development to commercialization by offering a complete biologic characterization solution. This solution consists of purpose-built instrumentation platforms and pre-validated off-the-shelf assays, as well as custom assays to meet the characterization challenges of increasingly complex biological therapeutics. That, combined with access to industry experts, saves valuable time and resources, leading to a robust data package that will guide success in every phase.


Biosafety Testing

A Comprehensive Portfolio of Test Methods to Ensure Biopharmaceutical Products Are Free of Contaminants

Explore Biosafety Testing

Protein Characterization

Successful IND Submission and Market Authorization Rely on Robust Protein Characterization for Every Stage of Development

Explore Protein Characterization

An Experienced Partner in Product Characterization

Consult Our Experts
meeting icon
Shorten your analytical development timelines

Accelerate your development timeline by skipping time-consuming assay development in favor of Sartorius’ validated analytical and safety assays to characterize your product.

Our ready-to-use, pre-qualified assays have been extensively tested with a range of molecules. More complex assays can be customized to meet your needs

Access insights and expertise when you need it

A dedicated client manager serves as a single point of contact. This individual develops a depth knowledge of your work and is positioned to provide concrete, individualized support. 

In addition, you have access to Sartorius’ extended team of experts — technical and regulatory teams available to discuss any challenge you might encounter related to your product characterization work

Count on integrated quality

Manufacturers can rely on the quality of Sartorius’ validated equipment and systems. During the development of early phase assays, Sartorius keeps an eye on future validation needs to ensure the transfer of assays to a regulated facility is fast and efficient. Sartorius’ facilities are fully cGMP compliant and have excellent audit track records with the FDA and EMA/MHRA

Related Assets


Orthogonal Chromatographic Techniques for Therapeutic Protein Characte...

Development of biotherapeutics, for example monoclonal antibodies (mAbs), requires a wide range of physicochemical and structural analysis...

Read Blog Article

Characterization of Protein Structure: The Value of Intact Mass Analys...

Intact mass analysis is the assessment of a protein’s total molecular weight  by mass spectrometry (MS) without prior digestion or fragmentation...

Read Blog Article

Why Glycan Analysis is an Essential Part of Therapeutic Protein Charac...

A recent report on the growth of the glycan analysis market¹ highlighted the importance of assessing the glycosylation of biotherapeutics.

Read Blog Article

Consult Our Experts

Consult Our Experts

Related Content


Cell Line Development

Learn More

Cell Banking

Learn More

Lot Release Testing

Learn More